Viral kinetic changes after 4 weeks and its relation to response to Peg. INF therapy in chronic HCV genotype 4 patients

Evaluation of the correlation between vitamin D receptor polymorphism and the response to treatment in chronic hepatitis C patients

Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Vitamin D serum level and CYP27B1-1260 promoter polymorphism in chronic hepatitis C patients treated with interferon

The effect of dual therapy of pegylated interferon and ribavirin on viral load and liver enzymes of hepatitis c patients

Correlation between lipid profile and rapid virological response to treatment of hepatitis C virus genotype IV with pegylated interferon alpha and ribavirin

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Sustained virological response rate to combined antiviral therapy in adult Egyptian patients with histologically mild chronic hepatitis C

Serum levels of AFP after interferon-based therapy with ribavirin for genotype 4 chronic HCV patients

Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients